Net Worth and Salary

Net Worth and Salary

Celebrity CEO Founding Member

Wendy Holman

Wendy Holman’s Net Worth is estimated $3 million.


Wendy Holman

Wendy Holman- Biography

Wendy Holman is the CEO of Ridgeback Biotherapeutics.

Wendy Holman’s Net Worth & Salary

Wendy Holman has made a lot of money working as an investor and as the CEO of Ridgeback Biotherapeutics.

Her net worth is estimated to be around $3 million dollars. She also earns money by giving interviews and attending different events.

Wendy Holman
Wendy Holman posing for a picture. Source: ridgebackbio

Wendy Holman Biography

Real Name Wendy Commins Holman
Birth Date 1980s
Age (as of 2021) 40s
Birth Place Miami Beach, Florida, United States
Nationality American
Profession CEO of Ridgeback Biotherapeutics
Religion Christianity
Sun sign Not Known

Physical Statistics

Height in feet inches – 5’ 7” – in Centimeters – 170 cm
Weight in Kilograms – 60 kg  –  in Pounds –  132 lbs
Shoe Size 7 (U.S.)
Hair Color Dark Brown
Eye Color Dark Brown
Body Type Slim

Qualification/Education

School Wharton School of the University of Pennsylvania
College Not Known

Relationship Status

Marital Status Married
Who is her husband? Dr. Wayne Holman
Children? None

Wendy Holman’s Bio

Wendy Holman is the CEO of Ridgeback Biotherapeutics, a company that is developing potential medications to treat infectious diseases with few or no treatment options, such as Ebola and Covid-19. CNBC News recently interviewed her about their potential Covid Pill, which they will release with their partner Merck & Co.

Wendy Holman’s Childhood & Education

Wendy Holman must be in her forties. She has not yet given the media any information about her exact birth date or location.

Details about her parents and siblings are also kept private. She had always wanted to do something as a child that would allow her to easily alleviate human suffering.

Wendy has finished high school but has not disclosed any information about her high school.

She later attended The Wharton School of the University of Pennsylvania. Based on her career, she must have taken a course in Biotechnology.

Wendy Holman’s Professional Career

She gained theoretical knowledge while in school, and after finishing her education, she began her career by applying that theoretical knowledge.

She joined Ziff Brothers Investments in August 1999 as Principal, Managing Director, and Director of Research. She had a 14-year career with them.

She joined the Sabin Vaccine Institute’s Board of Trustees in August 2017. The following year, she was appointed as a Trustee for Ransom Everglades School.

She was later seen as the CEO and Co-Founder of Ridgeback Biotherapeutics, owing to her extensive experience.

Her company has received FDA approval for Ebola treatment in 2020. The company is truly committed to helping everyday patients fight diseases and find solutions.

They recently partnered with Merck & Co., a pharmaceutical company based in the United States. They are hopeful that the antiviral pills they will be releasing will prevent Covid-19 deaths. Molnupiravir is the drug’s name, and it would be the first oral antiviral covid-19 drug.

Wendy Holman’s Personal Existence

Wendy’s husband’s name is Wayne. Ridgeback is a Biotherapeutics Company that she and her husband founded.

They married in a private wedding ceremony and have not revealed any details about it. Away from the spotlight, the couple is content to spend their lives together.

Also Read: Danny Porush,   Bill Gates,   Kristen Tomassi,    Stan Lee

Quick Facts of Wendy Holman

  • She currently resides in Miami Beach, Florida, in the United States of America.
  • In 2015, she was appointed to the University of Pennsylvania Libraries’ Board of Overseers.
  • In 2019, she was appointed to the President’s Advisory Council on HIV/AIDS.
  • Wendy used to spend her time at Rosengarten or the Law School Library while studying at Penn.
  • She and her colleagues are working on coronavirus and other new pathogen treatments.
  • She and her husband Wayne appeared on CNBC’s Squawk on the Street.

Popularity (Google Trends)